Consumer groups and a surgical association said they support the Food and Drug Administration’s proposal to require manufacturers of metal-on-metal (MoM) hip implants to submit premarket approval (PMA) applications.
The PMA process requires manufacturers to conduct clinical trials and is the most stringent standard for allowing devices on the market.
Consumers Union, the American Academy of Orthopaedic Surgeons (AAOS), and the National Research Center for Women & Families told FDA in comment letters that requiring a PMA submission is the best way to keep patients safe.
The agency’s proposed order “will finally require manufacturers to demonstrate clinical testing for safety ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.